 |
|
 |
 |
Scope of the Conference
There is increasing evidence that cancer and other mutation-related
diseases can be prevented not only by avoiding exposures to
recognized risk factors but also by favouring the intake of
protective factors and by modulating the defense mechanisms
of the host organism. This preventative strategy, referred to
as chemoprevention, can be pursued either by means of pharmacological
agents and/or by dietary factors, based on risk-benefit and
cost-benefit analyses. The efficacy and safety of chemopreventive
agents can be evaluated according to a variety of methodological
approaches, ranging from in vitro test systems to animal models
and studies in humans. An essential step is to understand the
mode of action of inhibitors of mutagenesis and carcinogenesis,
which provides a rational basis for their application. In a
period of exciting advancement of science in the general area
of molecular biology, mutagenesis and carcinogenesis, ICMAA-2007
will update the state of the art regarding the mechanisms of
inhibitors. |
| The ICMAA Series
ICMAA-2007 will be the 9th in a series of successful conferences
on mechanisms of antimutagenesis and anticarcinogenesis, held
every 2~3 years since 1985. The following is the list of the
previous conferences.
ICMAA-I:
Lawrence, Kansas (USA) October 16-20, 1985
ICMAA-II:
Ohito (Japan) December 4-9, 1988
ICMAA-III:
Il Ciocco (Italy) May 5-10, 1991 ICMAA-IV:
Banff (Canada) September 4-9, 1994 ICMAA-V:
Okayama (Japan) December 2-6, 1996 ICMAA-VI:
Arcachon (France) October 25-29, 1998 ICMAA-VII:
Grand Rapids (USA) September 23-27, 2000 ICMAA-VIII:
Pisa (Italy) September 23-27, 2003
At Grand Rapids (ICMAA-VII) it was decided to hold
future ICMAAs under the umbrella of IAEMS
(International Association of Environmental Mutagenesis Societies).
|
|
|